ARCHIVES

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

NDA n Vp-16 Goes to Advisory Committee Sept. 30

August 27, 1982

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

June 2, 2006

New Clinical Trials Monitoring Program To Site Visit PIs Every Three Years

July 30, 1982

DeVita Appointment Now Official; Calls For New Chemoprevention Program, More Applied Prevention

July 18, 1980

Researchers Uncover Tumors Sensitive to Chemotherapy

January 25, 2013